Toxicology Reports (Jan 2016)

Categorization of nano-structured titanium dioxide according to physicochemical characteristics and pulmonary toxicity

  • Naoki Hashizume,
  • Yutaka Oshima,
  • Makoto Nakai,
  • Toshio Kobayashi,
  • Takeshi Sasaki,
  • Kenji Kawaguchi,
  • Kazumasa Honda,
  • Masashi Gamo,
  • Kazuhiro Yamamoto,
  • Yasuhiro Tsubokura,
  • Shozo Ajimi,
  • Yoshiyuki Inoue,
  • Nobuya Imatanaka

Journal volume & issue
Vol. 3
pp. 490 – 500

Abstract

Read online

A potentially useful means of predicting the pulmonary risk posed by new forms of nano-structured titanium dioxide (nano-TiO2) is to use the associations between the physicochemical properties and pulmonary toxicity of characterized forms of TiO2. In the present study, we conducted intratracheal administration studies in rats to clarify the associations between the physicochemical characteristics of seven characterized forms of TiO2 and their acute or subacute pulmonary inflammatory toxicity. Examination of the associations between the physicochemical characteristics of the TiO2 and the pulmonary inflammatory responses they induced revealed (1) that differences in the crystallinity or shape of the TiO2 particles were not associated with the acute pulmonary inflammatory response; (2) that particle size was associated with the acute pulmonary inflammatory response; and (3) that TiO2 particles coated with Al(OH)3 induced a greater pulmonary inflammatory response than did non-coated particles. We separated the seven TiO2 into two groups: a group containing the six TiO2 with no surface coating and a group containing the one TiO2 with a surface coating. Intratracheal administration to rats of TiO2 from the first group (i.e., non-coated TiO2) induced only acute pulmonary inflammatory responses, and within this group, the acute pulmonary inflammatory response was equivalent when the particle size was the same, regardless of crystallinity or shape. In contrast, intratracheal administration to rats of the TiO2 from the second group (i.e., the coated TiO2) induced a more severe, subacute pulmonary inflammatory response compared with that produced by the non-coated TiO2. Since alteration of the pulmonary inflammatory response by surface treatment may depend on the coating material used, the pulmonary toxicities of coated TiO2 need to be further evaluated. Overall, the present results demonstrate that physicochemical properties may be useful for predicting the pulmonary risk posed by new nano-TiO2 materials. Keywords: Nano materials, Titanium dioxide, Intratracheal administration, Pulmonary toxicity, Risk assessment